Physical Functioning, Mental Health, and Quality of Life in Different Congenital Heart Defects: Comparative Analysis in 3538 Patients From 15 Countries.


Journal

The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280

Informations de publication

Date de publication:
02 2021
Historique:
received: 13 02 2020
revised: 28 03 2020
accepted: 29 03 2020
pubmed: 3 8 2020
medline: 22 6 2021
entrez: 3 8 2020
Statut: ppublish

Résumé

We compared physical functioning, mental health, and quality of life (QoL) of patients with different subtypes of congenital heart disease (CHD) in a large international sample and investigated the role of functional class in explaining the variance in outcomes across heart defects. In the cross-sectional Assessment of Patterns of Patient-Reported Outcome in Adults with Congenital Heart Disease-International Study (APPROACH-IS), we enrolled 4028 adult patients with CHD from 15 countries. Diagnostic groups with at least 50 patients were included in these analyses, yielding a sample of 3538 patients (median age: 32 years; 52% women). Physical functioning, mental health, and QoL were measured with the SF-12 health status survey, Hospital Anxiety and Depression Scale (HADS), linear analog scale (LAS) and Satisfaction with Life Scale, respectively. Functional class was assessed using the patient-reported New York Heart Association (NYHA) class. Multivariable general linear mixed models were applied to assess the relationship between the type of CHD and patient-reported outcomes, adjusted for patient characteristics, and with country as random effect. Patients with coarctation of the aorta and those with isolated aortic valve disease reported the best physical functioning, mental health, and QoL. Patients with cyanotic heart disease or Eisenmenger syndrome had worst outcomes. The differences were statistically significant, above and beyond other patient characteristics. However, the explained variances were small (0.6% to 4.1%) and decreased further when functional status was added to the models (0.4% to 0.9%). Some types of CHD predict worse patient-reported outcomes. However, it appears that it is the functional status associated with the heart defect rather than the heart defect itself that shapes the outcomes.

Sections du résumé

BACKGROUND
We compared physical functioning, mental health, and quality of life (QoL) of patients with different subtypes of congenital heart disease (CHD) in a large international sample and investigated the role of functional class in explaining the variance in outcomes across heart defects.
METHODS
In the cross-sectional Assessment of Patterns of Patient-Reported Outcome in Adults with Congenital Heart Disease-International Study (APPROACH-IS), we enrolled 4028 adult patients with CHD from 15 countries. Diagnostic groups with at least 50 patients were included in these analyses, yielding a sample of 3538 patients (median age: 32 years; 52% women). Physical functioning, mental health, and QoL were measured with the SF-12 health status survey, Hospital Anxiety and Depression Scale (HADS), linear analog scale (LAS) and Satisfaction with Life Scale, respectively. Functional class was assessed using the patient-reported New York Heart Association (NYHA) class. Multivariable general linear mixed models were applied to assess the relationship between the type of CHD and patient-reported outcomes, adjusted for patient characteristics, and with country as random effect.
RESULTS
Patients with coarctation of the aorta and those with isolated aortic valve disease reported the best physical functioning, mental health, and QoL. Patients with cyanotic heart disease or Eisenmenger syndrome had worst outcomes. The differences were statistically significant, above and beyond other patient characteristics. However, the explained variances were small (0.6% to 4.1%) and decreased further when functional status was added to the models (0.4% to 0.9%).
CONCLUSIONS
Some types of CHD predict worse patient-reported outcomes. However, it appears that it is the functional status associated with the heart defect rather than the heart defect itself that shapes the outcomes.

Identifiants

pubmed: 32739453
pii: S0828-282X(20)30317-2
doi: 10.1016/j.cjca.2020.03.044
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02150603']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

215-223

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Philip Moons (P)

KU Leuven Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Institute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden; Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa. Electronic address: philip.moons@kuleuven.be.

Koen Luyckx (K)

KU Leuven School Psychology and Development in Context, KU Leuven, Leuven, Belgium; UNIBS, University of the Free State, Bloemfontein, South Africa.

Corina Thomet (C)

KU Leuven Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Center for Congenital Heart Disease, Department of Cardiology, Inselspital-Bern University Hospital, University of Bern, Bern, Switzerland.

Werner Budts (W)

Division of Congenital and Structural Cardiology, University Hospitals Leuven, Leuven, Belgium; KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

Junko Enomoto (J)

Department of Education, Toyo University, Tokyo, Japan.

Maayke A Sluman (MA)

Coronel Institute of Occupational Health, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Department of Cardiology, Jeroen Bosch Hospital, 's Hertogenbosch, The Netherlands.

Chun-Wei Lu (CW)

Adult Congenital Heart Center, Department of Pediatrics, National Taiwan University Children's Hospital, Taipei, Taiwan.

Jamie L Jackson (JL)

Center for Biobehavioral Health, Nationwide Children's Hospital, Columbus, Ohio, USA.

Paul Khairy (P)

Adult Congenital Heart Center, Montréal Heart Institute, Université de Montréal, Quebec, Canada.

Stephen C Cook (SC)

Adult Congenital Heart Disease Center, Helen DeVos Children's Hospital, Grand Rapids, Michigan, USA.

Shanthi Chidambarathanu (S)

Pediatric Cardiology, Frontier Lifeline Hospital (Dr K. M. Cherian Heart Foundation), Chennai, India.

Luis Alday (L)

Division of Cardiology, Hospital de Niños, Córdoba, Argentina.

Katrine Eriksen (K)

Adult Congenital Heart Disease Center, Oslo University Hospital-Rikshospitalet, Oslo, Norway.

Mikael Dellborg (M)

Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden; Adult Congenital Heart Unit, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden; Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Sweden.

Malin Berghammer (M)

Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden; Department of Health Sciences, University West, Trollhättan, Sweden; Department of Paediatrics, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.

Bengt Johansson (B)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Andrew S Mackie (AS)

Division of Cardiology, Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada.

Samuel Menahem (S)

Monash Heart, Monash Medical Centre, Monash University, Melbourne, Australia.

Maryanne Caruana (M)

Department of Cardiology, Mater Dei Hospital, Birkirkara Bypass, Malta.

Gruschen Veldtman (G)

Adult Congenital Heart Disease Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Alexandra Soufi (A)

Department of Congenital Heart Disease, Louis Pradel Hospital, Hospices civils de Lyon, Lyon, France.

Susan M Fernandes (SM)

Adult Congenital Heart Disease Program at Stanford, Lucile Packard Children's Hospital and Stanford Health Care, Palo Alto, California, USA.

Kamila White (K)

Adult Congenital Heart Disease Center, Washington University and Barnes Jewish Heart & Vascular Center, University of Missouri, St Louis, Missouri, USA.

Edward Callus (E)

Clinical Psychology Service, IRCCS Policlinico San Donato, Milan, Italy; Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.

Shelby Kutty (S)

Adult Congenital Heart Disease Center University of Nebraska Medical Center/Children's Hospital and Medical Center, Omaha, Nebraska, USA; Taussig Heart Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Fouke Ombelet (F)

KU Leuven Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Silke Apers (S)

KU Leuven Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Adrienne H Kovacs (AH)

Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH